艾媒报告 |2019年猎聘同道APP产品分析及用户洞察研究报告
有您的支持，我们的分析师会做的更好 ！
本报告研究涉及企业/品牌包括:智联招聘、前程无忧、58同城、赶集网、拉勾网、脉脉、大街、BOSS直聘、斗米、兼职猫、招财猫直聘、店长直聘、中华英才网、领英、应届生求职网、智通人才
iiMedia Research(艾媒咨询)监测发现，猎聘同道的月活跃用户量为154.91万，在艾媒北极星求职招聘APP中排名第六，在垂直招聘类APP排名中继续稳坐首席，猎聘同道的成功，很大程度得益于其较为强大的猎头服务和较为精准的市场定位。然而，随着招聘行业逐渐进入成熟阶段，各大求职招聘类APP的用户渗透率总体平稳;新形势下，对于求职招聘类APP而言，深耕市场，提高服务或许才是唯一的出路。
The scale of China's bio-pharmaceutical industry continues to grow, and the proportion of bio-pharmaceutical output in the pharmaceutical industry continues to rise. In 2017, the total output value of the bio-pharmaceutical industry in China's park was about 1.5 trillion yuan. At present, China's biomedical industry has formed three major clusters, including the Bohai Rim region, the Yangtze River Delta region and the Pearl River Delta region, and the industrial agglomeration effect is outstanding. China's bio-pharmaceutical industry is in a stage of rapid development. In 2018, many head-to-head listed companies in biomedical related fields such as monoclonal antibodies, blood products and vaccines all exceeded 100 million yuan, achieving year-on-year growth. According to iiMedia Research, netizens in Shanghai are most concerned about the biomedical industry, and 40.9% of netizens surveyed support the application of transgenic technology in the pharmaceutical field. Among the heads of monoclonal antibodies, blood products and vaccines, Fuhong Hanlin as well as Weiguang Bio and Lidmanthe has the best online reputation,iiMedia Consulting analysts believe that in the future, the combination of artificial intelligence with new drug research and the fierce competition among head enterprises is an important trend in the development of China's biomedical industry.
权利声明
本报告由iiMedia Research（艾媒咨询）出品，文件所涉的文字、图片、商标、表格、视频等均受中华人民共和国知识产权相关法律保护，经许可引用时请注明报告来源。
未经艾媒咨询许可，任何组织或个人均不得以任何形式擅自使用、复制、转载本报告或向第三方实施许可，否则，艾媒咨询将保留追究其一切法律责任之权利。
免责声明
本报告所涉之统计数据，主要由行业访谈、用户调研、市场调查、桌面研究等样本数据，结合专业人员分析及艾媒咨询大数据系统监测、艾媒相关数据分析模型科学计算获得。由于调研样本及计算模型的影响与限制，统计数据仅反映调研样本及模型计算的基本情况，未必能够完全反映市场客观情况。鉴于上述情形，本报告仅作为市场参考资料，艾媒咨询不因本报告（包括但不限于统计数据、模型计算、观点等）承担法律责任。
阅读、使用本报告前，应先审慎阅读及充分理解上述法律声明之内容。阅读、使用本报告，即视为已同意上述法律声明；否则，请勿阅读或使用本报告。
网友评论
只有购买过该报告的用户才能进行评论哦！